Ligand Pharmaceuticals Inc (LGND)
70.90
+1.01
(+1.45%)
USD |
NASDAQ |
Apr 24, 16:00
70.90
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals Total Assets (Quarterly): 787.22M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 787.22M |
| September 30, 2023 | 769.23M |
| June 30, 2023 | 758.10M |
| March 31, 2023 | 811.08M |
| December 31, 2022 | 762.67M |
| September 30, 2022 | 1.051B |
| June 30, 2022 | 1.076B |
| March 31, 2022 | 1.105B |
| December 31, 2021 | 1.298B |
| September 30, 2021 | 1.274B |
| June 30, 2021 | 1.256B |
| March 31, 2021 | 1.295B |
| December 31, 2020 | 1.362B |
| September 30, 2020 | 1.247B |
| June 30, 2020 | 1.243B |
| March 31, 2020 | 1.186B |
| December 31, 2019 | 1.495B |
| September 30, 2019 | 1.547B |
| June 30, 2019 | 1.802B |
| March 31, 2019 | 1.914B |
| December 31, 2018 | 1.261B |
| September 30, 2018 | 2.106B |
| June 30, 2018 | 1.858B |
| March 31, 2018 | 754.67M |
| December 31, 2017 | 671.02M |
| Date | Value |
|---|---|
| September 30, 2017 | 662.34M |
| June 30, 2017 | 640.02M |
| March 31, 2017 | 629.72M |
| December 31, 2016 | 601.58M |
| September 30, 2016 | 600.86M |
| June 30, 2016 | 616.80M |
| March 31, 2016 | 613.44M |
| December 31, 2015 | 503.06M |
| September 30, 2015 | 521.70M |
| June 30, 2015 | 304.76M |
| March 31, 2015 | 263.22M |
| December 31, 2014 | 258.03M |
| September 30, 2014 | 272.28M |
| June 30, 2014 | 99.85M |
| March 31, 2014 | 105.47M |
| December 31, 2013 | 104.71M |
| September 30, 2013 | 101.68M |
| June 30, 2013 | 99.57M |
| March 31, 2013 | 98.36M |
| December 31, 2012 | 104.26M |
| September 30, 2012 | 97.51M |
| June 30, 2012 | 104.59M |
| March 31, 2012 | 111.80M |
| December 31, 2011 | 120.58M |
| September 30, 2011 | 122.47M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
758.10M
Minimum
Jun 2023
1.802B
Maximum
Jun 2019
1.165B
Average
1.243B
Median
Jun 2020
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals Inc | 904.42M |
| ADMA Biologics Inc | 329.18M |
| Viking Therapeutics Inc | 368.49M |
| Corcept Therapeutics Inc | 621.52M |
| Palatin Technologies Inc | 13.55M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 86.30M |
| Shareholders Equity (Quarterly) | 700.91M |
| Current Ratio | 14.15 |
| Net Debt Paydown Yield | 1.22% |